Press release
Long-Acting Implantable GLP-1 Obesity Devices Market Forecast 2026-2036: Market to Reach USD 932.9 Million by 2036 at 28.50% CAGR
The long-acting implantable GLP-1 obesity devices market is gaining traction as healthcare systems address real-world patient adherence challenges. By transitioning from patient-administered injectables to physician-controlled, continuous-release implants, the market is redefining obesity treatment economics and clinical workflows.
Read Full Report-https://www.futuremarketinsights.com/reports/long-acting-implantable-glp-1-obesity-devices-market
Market snapshot: global market 2026 - 2036
Market size 2026: USD 76.0 Million
Market size 2036: USD 932.9 Million
CAGR (2026-2036): 28.50%
Leading product segments: baking accessories 25.6% and grilling & frying 45.1%
Leading material type: 58.1% disposable
Leading end use: 51.9% residential
Key growth regions: North America, Europe, Asia Pacific
Top companies: Vivani Medical, Inc., DelSiTech Ltd., Delpor, Inc., Evonik Health Care, Corbion, Ashland Inc., Poly-Med, Inc.
Market Momentum (YoY Path)
The long-acting implantable GLP-1 obesity devices market demonstrates a steep upward trajectory beginning at USD 59.1 million in 2025 and reaching USD 76.0 million in 2026. By 2028, the market begins scaling as early clinical validation strengthens, followed by accelerated adoption in 2030 and 2031 as regulatory pathways mature. Growth intensifies through 2033 with expanded clinical deployment, ultimately reaching USD 932.9 million by 2035, signaling the transition from precommercial validation to large-scale commercialization.
Why the Market is Growing
Growth in the long-acting implantable GLP-1 obesity devices market is driven by the urgent need to address therapy abandonment in obesity care. Managed care organizations are shifting toward delivery systems that eliminate patient-controlled dosing. Additionally, the high cost of unused injectable therapies is pushing procurement teams toward single-intervention solutions. Continuous-release polymer platforms also offer developers a scalable pathway to monetize proprietary drug delivery technologies.
Segment Spotlight
Product Type
Grilling & frying accounts for 45.1% share, reflecting dominant demand dynamics. In parallel, exenatide implants lead with 54.0% share due to their established safety profile, making them ideal for validating implant-based delivery systems. Developers rely on these legacy molecules to isolate mechanical safety and streamline regulatory approval.
Material Type
Disposable materials hold a 58.1% share, aligning with the need for hygiene and simplified clinical workflows. In the implant context, subdermal NanoPortal-type solid implants dominate with 41.0% share due to predictable release kinetics and retrievability, ensuring safety and compliance.
End Use
Residential usage leads with 51.9% share, reflecting broader adoption trends. Within clinical settings, specialty obesity and endocrinology clinics account for 47.0% share, supported by their capability to perform minor surgical procedures and manage long-term metabolic therapies effectively.
Drivers, Opportunities, Trends, Challenges
Drivers
The primary growth driver is the high rate of real-world therapy discontinuation. Payers are demanding solutions that ensure 12-month persistence, pushing the adoption of implantable delivery systems over traditional injectables.
Opportunities
Significant opportunities exist in biomaterial integration and next-generation peptide formulation. CDMO partners capable of producing ultra-pure polymers are positioned to secure high-value contracts, while dual-action implant formulations open new therapeutic possibilities.
Trends
A key trend is the transition from pharmacy-based distribution to physician-administered procedural models. This shift is reshaping reimbursement structures and aligning treatment delivery with clinical oversight.
Challenges
The main challenge is the operational shift to minor surgical procedures. Limited procedural training, lack of dedicated time slots, and evolving reimbursement codes are slowing broader adoption outside specialized clinics.
Competitive Landscape
The long-acting implantable GLP-1 obesity devices market is highly concentrated due to significant technical and capital barriers. Early leaders such as Vivani Medical, Inc., DelSiTech Ltd., and Delpor, Inc. dominate through validated clinical data and proprietary delivery platforms. Material science leaders including Evonik Health Care, Corbion, and Ashland Inc. play a critical role in supplying specialized polymers. The market is expected to consolidate further as large biopharmaceutical companies pursue vertical integration to secure long-term competitive advantage.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates:https://www.futuremarketinsights.com/reports/brochure/rep-gb-32361
Get Access of Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-32361
Scope of the Report
Market size: USD 76.0 Million (2026) to USD 932.9 Million (2036)
CAGR: 28.50% (2026-2036)
Segmentation: Molecule Type, Duration Profile, Technology Platform, Care Setting, End-user Group
Regions: North America, Europe, Asia Pacific
Countries: China, India, Australia, United States, United Kingdom, Germany, Japan, and 40+ others
Key companies: Vivani Medical, Inc., DelSiTech Ltd., Delpor, Inc., Evonik Health Care, Corbion, Ashland Inc., Poly-Med, Inc.
FAQ
How large is the market in 2026?
The long-acting implantable GLP-1 obesity devices market is valued at USD 76.0 million in 2026, reflecting its early-stage, clinical-validation phase.
What will the market be worth by 2036?
It is projected to reach USD 932.9 million by 2036, driven by regulatory approvals and large-scale adoption.
What is the expected CAGR?
The market is expected to grow at a CAGR of 28.50% between 2026 and 2036.
Which molecule type leads the market?
Exenatide implants lead with a 54.0% share due to their established safety and suitability for early-stage validation.
Which duration profile dominates?
6-month implants lead with a 58.0% share, aligning with clinical workflows and billing cycles.
What drives market growth?
Growth is driven by the need to solve therapy discontinuation and ensure long-term treatment adherence.
What is the key challenge?
The transition from prescription-based models to procedural interventions remains the primary operational hurdle.
Which country grows the fastest?
China leads with a CAGR of 32.4%, followed by India at 31.6%.
Explore More Related Studies Published by FMI Research:
Hydrocephalus Shunt Market: https://www.futuremarketinsights.com/reports/hydrocephalus-shunt-market
Endoscopic Closure Systems Market: https://www.futuremarketinsights.com/reports/endoscopic-closure-systems-market
Mammalian Transient Protein Expression Market: https://www.futuremarketinsights.com/reports/mammalian-transient-protein-expression-market
Home Sleep Apnea Testing Market: https://www.futuremarketinsights.com/reports/home-sleep-apnea-testing-market
Lacrimal Devices Market: https://www.futuremarketinsights.com/reports/lacrimal-devices-market
Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi
Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Long-Acting Implantable GLP-1 Obesity Devices Market Forecast 2026-2036: Market to Reach USD 932.9 Million by 2036 at 28.50% CAGR here
News-ID: 4439741 • Views: …
More Releases from Future Market Insights
Microneedle Patch Influenza Vaccine Delivery Market Forecast 2026-2036: Market t …
NEWARK, DE | The Microneedle Patch Influenza Vaccine Delivery Market is valued at USD 19.5 million in 2025 and is expected to reach USD 24.0 million in 2026, expanding at a CAGR of 23.00% through 2036. The market is projected to surge to USD 190.2 million by 2036, driven by the global shift from cold-chain dependent liquid vaccines to thermostable, self-administered patch-based delivery systems. This transformation is redefining public health…
Global Egg Replacement Ingredient Market Driven by Plant-Based Shift Across Euro …
According to analysis by Future Market Insights (FMI), the global egg replacement ingredient market is entering a phase of structured expansion as food manufacturers increasingly shift toward plant-based formulations to ensure supply stability, reduce allergen risks, and meet evolving sustainability mandates. Rising volatility in egg supply chains, coupled with stricter animal welfare regulations and corporate clean-label commitments, is reshaping procurement strategies and formulation practices across the food industry.
The market surpassed…
Global Egg Replacement Ingredient Market Driven by Plant-Based Shift Across Euro …
According to analysis by Future Market Insights (FMI), the global egg replacement ingredient market is entering a phase of structured expansion as food manufacturers increasingly shift toward plant-based formulations to ensure supply stability, reduce allergen risks, and meet evolving sustainability mandates. Rising volatility in egg supply chains, coupled with stricter animal welfare regulations and corporate clean-label commitments, is reshaping procurement strategies and formulation practices across the food industry.
The market surpassed…
Grape Seed Extract in Pet Food Application Market Expands with EU Dominance, Led …
According to analysis by Future Market Insights (FMI), the EU grape seed extract market in pet food applications is entering a phase of structured expansion as functional pet nutrition, botanical ingredient adoption, and regulatory-driven quality standards reshape value creation across the category. Increasing demand for antioxidant-rich, plant-based ingredients in premium and super-premium pet food, combined with rising veterinary recommendations and pet humanization trends, is redefining formulation strategies and pricing dynamics…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population?
The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
